Business Wire

Busan Set to Host BOF 2019 for Global K-POP Lovers This October

Share

Busan One Asia Festival (BOF), a festival for everyone who loves K-POP around the world, is slated to open from the 19th to 25th of October in the attractive city of Busan, harmonized by the sea, mountains and rivers.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191002005009/en/

Busan One Asia Festival (BOF) 2019 will be held from October 19th to 25th in the attractive city of Busan. The festival is preparing upgraded contents in order to provide enjoyable experiences for visitors. First, a star-studded K-POP Concert will open up the grand festival on the 19th of October with a lineup that features AB61X, ITZY, HA SUNG WOON, KIM JAE HWAN and KIM SE JEONG, at a beautiful sunset spot, Hwamyung Eco Park. Family Park Concert will mark the finale of the festival on the 25th. Through the powerful music, audience will all become one regardless of age. Stray Kids, Lovelyz and JBJ95 will also join the finale and make a promise to meet again at BOF 2020. The photo shows 2018 Busan One Asia Festival Closing Performance. (Photo: Business Wire)

Busan One Asia Festival (BOF) 2019 will be held from October 19th to 25th in the attractive city of Busan. The festival is preparing upgraded contents in order to provide enjoyable experiences for visitors. First, a star-studded K-POP Concert will open up the grand festival on the 19th of October with a lineup that features AB61X, ITZY, HA SUNG WOON, KIM JAE HWAN and KIM SE JEONG, at a beautiful sunset spot, Hwamyung Eco Park. Family Park Concert will mark the finale of the festival on the 25th. Through the powerful music, audience will all become one regardless of age. Stray Kids, Lovelyz and JBJ95 will also join the finale and make a promise to meet again at BOF 2020. The photo shows 2018 Busan One Asia Festival Closing Performance. (Photo: Business Wire)

As BOF marks its 4th year, the 2019 festival is preparing upgraded contents in order to provide enjoyable experiences for visitors. First, a star-studded K-POP Concert will open up the grand festival on the 19th of October with a lineup that features AB61X, ITZY, HA SUNG WOON, KIM JAE HWAN and KIM SE JEONG, at a beautiful sunset spot, Hwamyung Eco Park. Family Park Concert will mark the finale of the festival on the 25th. Through the powerful music, audience will all become one regardless of age. Stray Kids, Lovelyz and JBJ95 will also join the finale and make a promise to meet again at BOF 2020.

BOF Land will take place at Gunam-ro, nearby the famous beautiful beach of Haeundae. BOF Land is a cultural playground to see, play, take a photo, as well as enjoy a variety of K-culture contents. Visitors will indeed be full of excitement.

This year, the festival is featuring a new public audition project: Music Lable On BOF, in collaboration with CUBE Entertainment. The next BOF K-POP stars will be born at this event. The recruitment process will open by the 24th of September. Winners will be guaranteed a spot to perform on the special stage and become trainees of major entertainment companies.

This is not the end. Another special event is waiting for hip hop lovers. Top hip hop artists including Simon Dominic, Punchnello and Hoody will perform at the Hip Hop Mashup Concert and will heat up Busan with their passion. The concert will take place at the Busan Cinema Center on the 20th of October.

As well, visitors will find joy in Busan’s authentic culture, the new wave of Hallyu and attractions in every corner of the city. Those who wish to participate can find details through the official website (www.bof.or.kr) and Facebook page (www.facebook.com/BusanOneAsiaFestival).

Contact information

Busan Metropolitan City
Ryoo Hying-Suk,
+82-51-888-1314
aaaa6444@korea.kr

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex and Republic of Ireland Expand Long-Term Cystic Fibrosis Medicines Reimbursement Agreement to Include Triple Combination Therapy for All Eligible Patients Ages 12 and Over Once Licensed13.12.2019 21:55:00 EETPress release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirmed that, following recent collaborative discussions, it has negotiated an agreement with the Health Service Executive (HSE) in the Republic of Ireland to expand the existing long-term cystic fibrosis (CF) reimbursement agreement to include the triple combination regimen (elexacaftor, tezacaftor and ivacaftor), which is under review and pending approval by the European Medicines Agency, for all eligible patients ages 12 and older in line with the potential future licensed indication. This expands the existing agreement which had already included access to current and future Vertex medicines for people in Ireland with CF of any age who: Have one of the specified mutations as included in the KALYDECO® marketing authorization (G551D, G551S, S549R, G1244E, S1251N, G1349D, S1255P, G178R or S549N) or Are homozygous for the F508del mutation or Are heterozygous for the F508del mutation and have a specified mutation (P67L, D579G, D1

CreditLens™ Solution Receives SOC 2 Attestation Report13.12.2019 18:17:00 EETPress release

Moody’s Analytics announced today that the CreditLens software-as-a-service (SaaS) solution has received an attestation report from the American Institute of Certified Public Accountants (AICPA) System and Organization Controls (SOC 2). The SOC 2 report details the security and availability of customer data in the CreditLens SaaS solution, and denotes its adherence to the AICPA’s security and availability controls standards. Built on the latest cloud-based technology, the CreditLens platform helps businesses digitally transform their commercial credit processes to make faster and better-informed decisions. It facilitates process automation and helps clients improve their efficiency, reduce errors, and streamline workflows. A SOC 2 report ensures that a company’s information security measures are in line with the unique parameters of today’s cloud requirements. The report addresses a service organization's controls that relate to operations and compliance, as outlined by the AICPA's Tru

CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible13.12.2019 14:47:00 EETPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for Darzalex®▼ (daratumumab) to include the use of daratumumab in combination with bortezomib, thalidomide and dexamethasone (VTd) for the treatment of adult patients with newly diagnosed patients with multiple myeloma who are eligible for autologous stem cell transplant (ASCT). The Positive Opinion is supported by data from Part 1 of the Phase 3 CASSIOPEIA (MMY3006) study, published in The Lancet 3 in June 2019, and presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting. Additional information about this study can be found at www.ClinicalTrials.gov (NCT02541383). “Today’s Opinion takes us a step closer to offering the first daratumumab combination regimen to transplant eligible patients, redefining treatment for those people newl

Janssen Receives Positive CHMP Opinion for Expanded Use of Erleada® (apalutamide) for Patients with Metastatic Hormone-Sensitive Prostate Cancer13.12.2019 14:40:00 EETPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending approval for expanding the use of Erleada® (apalutamide) to include the treatment of adult men with metastatic hormone-sensitive prostate cancer (mHSPC) in combination with androgen deprivation therapy (ADT).2 The CHMP’s Positive Opinion will now be reviewed by the European Commission (EC), which has the authority to grant approval for the new use of apalutamide. The Positive Opinion is based on data from the Phase 3 TITAN study, which assessed the addition of apalutamide to ADT – the current standard of care in mHSPC – in a broad range of patients with mHSPC, regardless of disease volume, prior treatment with docetaxel or staging at initial diagnosis. The dual primary endpoints of the study were overall survival (OS) and radiographic progression-free survival (rPFS). Ap

German Player Karl Rupprec Wins 2019 Boyaa Poker Tournament Europe13.12.2019 12:24:00 EETPress release

On December 8, the sixth edition of the BPT (Boyaa Poker Tournament) came to an end. King's Resort in the Czech Republic celebrated this BPT Europe that enjoyed 600 cumulative participants from 20 countries. In the end, Karl Rupprec, from Germany, won the Main Event Championship. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005109/en/ (Photo: Business Wire) Highlights of the BPT Europe 2019 final The BPT Europe 2019 Main Event began on December 8 at 2:00 p.m., Czech Republic time. After 9 hours of Texas Poker, players Ondrej Drozd from the Czech Republic and Karl Rupprec from Germany reached the last heads-up. In the end, Karl Rupprec, who started with half of his opponent's chips, reversed the situation with his two nines, winning the championship. Heads-up Highlights: Karl Rupprec pair 9 and Ondrej Drozd 2, 5. The flop was 2, Q, 9, so Karl Rupprec got three of a kind, and Ondrej Drozd got pair 2. Rupprec pretended

Seoul Semiconductor’s SunLike Series Natural Spectrum LEDs Adopted by Italian Designed Architectural Lighting Brand for Motorized Luminaire with Smart Wireless Controls13.12.2019 12:00:00 EETPress release

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a leading global innovator of LED technology, announced that it has achieved smart lighting design with SunLike Series natural spectrum LEDs in cooperation with Casambi Technologies Oy (“Casambi”), a leading developer of wireless lighting control systems based on Bluetooth Low Energy (BLE), and it has been adopted for the Italian designed architectural lighting brand formalighting Ltd. (“formalighting”), a global manufacturer of Italian designed architectural lighting systems and solutions for a new product line which offers motorized luminaire with smart wireless controls. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191213005009/en/ SunLike implemented in motion lamps (Photo: Business Wire) The SunLike COB LED packages have been adopted by formalighting for the new fixtures, Moto-Zero 40 Compasso and Moto-Zero 66 Zoom, in track mounted motorized spotlight range. In this sect

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom